HOME >> BIOLOGY >> NEWS
Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart

BETHESDA, MD (August 18, 2004) - Despite improvements in earlier diagnosis and treatment, cardiovascular disease is far and away the leading cause of death in the U.S. and the world.

According to the latest posted statistics, heart disease causes 700,000 deaths in the U.S. each year, with the number of adults diagnosed with heart disease exceeding 23 million, or 11.5% of the adult population.

Previously thought of as concentrated in rich countries, ischemic heart and related cerebrovascular diseases alone caused an estimated 17 million or 23.2% of deaths globally in 2000, WHO reported.

A contributing cause of what some have called a pandemic is that in contrast to many other organs in the body, the heart has only a minimal capability for self-renewal, leaving most current therapies to address symptoms with little hope of rehabilitating the injured heart itself after a heart attack (myocardial infarction).

The regenerative potential of stem cells in relation to the muscle layer of the heart wall (or myocardium) has been recently recognized, but how this might translate into therapeutic uses to repair the heart has been limited.

Mayo Clinic team demonstrates potential for "rebuilding" damaged heart

Using embryonic stem cells, Mayo Clinic researchers transformed these master cell types into fully functional cardiac cells and transplanted them into damaged regions of the myocardium, where the cells integrated into the infarct and showed rapid and robust improvements, which were stable over an extended period post-therapy.

The study, entitled "Stable benefit of embryonic stem cell therapy in myocardial infarction," appears in the August 2004 edition of the American Journal of Physiology-Heart and Circulatory Physiology, one of 14 peer-reviewed journals published by the American Physiological Society.

The investigative team under the direction of Andre Terzic included Denice M. Hodgson, Atta Behf
'"/>


18-Aug-2004


Page: 1 2 3

Related biology news :

1. Embryonic stem cell - based tissue engineering may help repair damaged heart muscle
2. Embryonic skin cells committed at an early age
3. Embryonic pig cell transplants halt rat diabetes
4. Embryonic pathway critical to growth of digestive tract tumors
5. Embryonic hope for damaged spines
6. Embryonic facial development subject to insult or repair longer than expected
7. Embryonic mouse stem cells reduce symptoms in model for Parkinsons disease
8. Statement Of The DFG Concerning "Questions Of Human Embryonic Stem Cells"
9. Molecular Control Mechanism Of Embryonic Development Unraveled
10. First Derivation Of Human Embryonic Stem Cells Reported In Science
11. Hopkins Research Team Cultures Long-Awaited Human Embryonic Stem Cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2019)... ... ... SFC Fluidics, Inc. (SFC) has partnered with two companies, Diabeloop ... was awarded to SFC Fluidics in 2018 by JDRF. , JDRF is sponsoring this ... people with type 1 diabetes (T1D). By accelerating the development of a next-generation miniaturized ...
(Date:5/14/2019)... , ... May 13, 2019 , ... ... in the BIOMEDevice Expo in Boston on May 15-16, 2019, the largest medical ... industry including, MedTech, design engineering, and embedded systems product organizations. , They will ...
(Date:5/8/2019)... ... 2019 , ... MMS Holdings – an award-winning, data-focused contract ... Medrio , the leading provider of eClinical technology for small to mid-sized pharmaceutical ... position high-quality CRO services with Medrio’s fast and easy-to-use eClinical products, MMS is ...
Breaking Biology News(10 mins):
(Date:5/4/2019)... ... May 03, 2019 , ... More ... the Dakila Pesquisas Association, the scientist and ufologist Urandir Fernandes de Oliveira, last ... Urandir detailed the results of some research carried out by the association, in ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from Ambry Genetics ... between U.S. insurer policies for genetic testing and the 2019 National Comprehensive Cancer ... ovarian cancer (HBOC). , Jill S. Dolinsky, director of clinical affairs ...
(Date:4/16/2019)... FREDERICK, Md. (PRWEB) , ... April 16, 2019 ... ... will honor Blue Sources and their project partner, the U.S. Army Center for ... Retransfer of Aquatic Biomonitor Through Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company ...
(Date:4/10/2019)... ... 2019 , ... After more than three months of renovation, Lajollacooks4u is set ... updated appliances and modern lighting and fixtures, and will provide additional workspace for the ... tremendous growth in the demand for our team-building events and cooking classes over the ...
Breaking Biology Technology:
Cached News: